Page 39 - வரையறுக்கப்பட்டவை நன்மை இழப்பெதிர்காப்புப் திட்டங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வரையறுக்கப்பட்டவை நன்மை இழப்பெதிர்காப்புப் திட்டங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வரையறுக்கப்பட்டவை நன்மை இழப்பெதிர்காப்புப் திட்டங்கள் Today - Breaking & Trending Today

Business of "Swarnamahal Financial Services PLC" suspended by CBSL - Hiru News - Srilanka's Number One News Portal, Most visited website in Sri Lanka


Monday, 12 April 2021 - 19:17
The Monetary Board of the Central Bank of Sri Lanka (Monetary Board) has decided to suspend business of Swarnamahal Financial Services PLC (SFSP), in terms of Section 31(1) of the Finance Business Act, No. 42 of 2011 (FBA) with effect from 5:00 p.m. on 12th April 2021.
Having considered the continuously deteriorating financial condition and non-availability of a viable revival plan, the Monetary Board decided to suspend the business of SFSP and its parent Company ETI Finance Limited (ETIF) in terms of Section 31(1) of the FBA with effect from 13th July 2020 and the period of suspension of business activities was in effect until 12th January 2021. ....

Sri Lanka , People Bank , Panel Of Management , Swarnamahal Financial Services , Monetary Board Of The Central Bank , Monetary Board , Central Bank , Finance Business Act , Suspension Order , Hirunews Lk English , Per Cent , ஸ்ரீ லங்கா , மக்கள் வங்கி , குழு ஆஃப் மேலாண்மை , பண பலகை ஆஃப் தி மைய வங்கி , பண பலகை , மைய வங்கி , நிதி வணிக நாடகம் , இடைநீக்கம் ஆர்டர் , ஒன்றுக்கு சதவீதம் , கொண்டு வாருங்கள் , இடைநீக்கம் செய்யப்பட்டது ,

Mawson Gold Limited: Mawson Defines Two New Areas in First Winter Drilling Results from Finland Drills 70.3 m @ 1.6 g/t AuEq at The Hut and 1.5 m @ 19.6 g/t AuEq at Joki East


Mawson Gold Limited: Mawson Defines Two New Areas in First Winter Drilling Results from Finland Drills 70.3 m @ 1.6 g/t AuEq at The Hut and 1.5 m @ 19.6 g/t AuEq at Joki East
Mawson Gold Limited
( Mawson ) or (the Company ) (TSX:MAW) (Frankfurt:MXR) (PINKSHEETS: MWSNF) is pleased to announce results from two new areas that are located outside and adjacent to current resource areas. These results deliver the thickest mineralized zone found at Rajapalot to date at The Hut and continue to extend high-grade mineralization at Joki East. Fifteen diamond drill holes are reported as part of the Company s 76 hole, 19,422 metre 2020/21 drill program at the Company s 100%-owned Rajapalot project in Finland. ....

Northern Ostrobothnia , British Columbia , Mawson Rovaniemi , Michael Hudson , Kurt Simon Forrester , Nick Cook , Rodney Webster , Nick Cook Faus , National Instrument , Winter Drill Program , Mawson Gold , Geologist For The Company , Mawson Gold Limited , Geological Survey Of Finland , Australasian Institute Of Mining Metallurgy , Joki East , Geological Survey , Finland Uniform Coordinate System , Chief Geologist , Australasian Institute , Mining Metallurgy , Arn Perspective , Property Mineral Resource Estimate , Updated Technical Report , Updated Technical , Mineral Projects ,

Immunocore Holdings Limited: Immunocore presents phase 3 data comparing tebentafusp with investigator's choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting


(2)
PRESS RELEASE
Immunocore presents phase 3 data comparing tebentafusp with investigator s choice in the clinical trial plenary session at the
American Association for Cancer Research 2021 Annual Meeting
Tebentafusp is the first investigational therapy to improve Overall Survival (OS) in patients with metastatic uveal melanoma
First positive Phase 3 clinical trial for any T cell receptor therapeutic and first for any bispecific in a solid tumor
(Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, presented data from a phase 3 randomized trial comparing tebentafusp (IMCgp100) with investigator s choice in first-line metastatic uveal melanoma (mUM) in the clinical trial plenary session at the American Association for Cancer Research (AACR) Annual Meeting 2021. ....

Baden Wuberg , United States , Marcuso Butler , Jessicac Hassel , Immunocore Imm , Debra Nielsen , Clayton Robertson , Head Of Communications , Exchange Commission On , University Hospital Heidelberg , Exchange Commission , Princess Margaret Cancer Centre , Company Annual Report On Form , American Association For Cancer Research , Oriented Innovative Clinical Research , Consilium Strategic Communications , Cancer Research , Overall Survival , American Association , Annual Meeting , Saturday April , Monday April , Disease Oriented Innovative Clinical Research , Jessica Hassel , Against Cancer , Breakthrough Therapy Designation ,